Qualifications: FRCR (2005), MD (2007), MRCP (1999), BMBS (1994), B.Med.Sci (1992)
GMC Number: 4094805
Clinical Areas of Interest: Advanced colorectal malignancy, Anal cancer, Biomarkers, Bowel cancer, Chemotherapy, Early rectal cancer, Outcomes and quality of life and Patient voice
Regional Chapter: South Wales
Richard Adams is Professor of Cancer Clinical Trials, Director of the CRUK core funded Centre for Trials Research (Cancer Division), Clinical Director of the Wales Cancer Biobank and Honorary Consultant Clinical Oncologist at Cardiff University and Velindre Cancer Centre. His clinical practice and research is focused on lower gastrointestinal cancers. He is chair of the National Cancer Research Institute (NCRI) Colorectal group and the radiotherapy and early phase national CTRad research group , Chair of the CRUK Clinical Expert Review Panel and is active in national and international research organisations including IRCI the International Rare Cancer Initiative (for anal cancer), ESMO and ARCAD.
Richard is a Chief investigator on lower gastrointestinal cancer trials and leads on radiotherapy quality assurance programmes for UK anal and rectal cancer radiotherapy trials. He oversees collaborative translational research in numerous phase II/ III colorectal cancer trials. He was a founder member of and now chairs the South Wales Cancer Care link with Sierra Leone.